Celldex Therapeutics, Inc. (CLDX) Operating cash flow 2016–2025
Celldex Therapeutics, Inc. (CLDX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$210.9MFY2025 · since FY2016: -$113.0M → -$210.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$210.9M | -33.7% |
| FY2024 | -$157.8M | -47.1% |
| FY2023 | -$107.3M | -3.4% |
| FY2022 | -$103.7M | -70.3% |
| FY2021 | -$60.9M | -50.7% |
| FY2020 | -$40.4M | +13.0% |
| FY2019 | -$46.4M | +38.3% |
| FY2018 | -$75.2M | +24.7% |
| FY2017 | -$99.9M | +11.6% |
| FY2016 | -$113.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice